UK: GlaxoSmithKline silent on talk of private equity swoop for Lucozade, Ribena

By Andy Morton | 11 March 2013

GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.

just-drinks articles are only available to registered users and members.

Join now for increased access

There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.

If you’re already a member, login here.

GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.

  • Unlimited access to all the latest global beverage news and insight
  • Expert analysis that puts the news into context
  • Exclusive interviews with leading industry figures
  • Monthly management briefings with detailed analysis on hot topics
  • Personalised RSS feeds and email newsletters
  • 10-year archive of news, insight and intelligence
  • Discounts on just-drinks market research
  • Plus much more

If you’re already a member, login here

Not what you were looking for?

Search just-drinks:

just-drinks tagline

Not a member? Join here

Decrease font sizeDecrease font sizeDecrease font size Increase font sizeIncrease font sizeIncrease font size Comment on this article Email this to a friend Print this page